KEYTRUDA Plus Standard Therapy Boosts Event-Free Survival in Resectable Head and Neck Cancer Merck , known as MSD outside the United States and Canada, has announced landmark findings from its Phase 3 KEYNOTE-689 clinical trial evaluating the efficacy of KEYTRUDA®…
Gameto Launches First U.S. Clinical Site for Patient Enrollment in Fertilo Study Gameto, a clinical-stage biotechnology company at the forefront of developing cutting-edge iPSC (induced pluripotent stem cell)-based therapies to revolutionize fertility care, today announced an exciting milestone in its…
Gilead Sciences Reports Financial Results for First Quarter 2025 Gilead Sciences, Inc. (Nasdaq: GILD) has unveiled its financial and operational performance for the first quarter of 2025, underscoring a steady start to the year that reflects both commercial momentum and…
Creyon Bio Names Industry Veteran Serge Messerlian as CEO to Drive Growth and Partnerships Creyon Bio, a biotechnology company pioneering the use of artificial intelligence in oligonucleotide therapy development, has announced a major leadership transition with the appointment of Serge…
Pfizer Champions a New Era in Personalized Cancer Care at ASCO 2025 Annual Meeting Pfizer Inc. (NYSE: PFE), a global leader in biopharmaceutical innovation, announced its robust presence at the 2025 American Society of Clinical Oncology (ASCO®) Annual Meeting, which…
Halda Therapeutics Names Dr. Eyal Attar as New Chief Medical Officer Halda Therapeutics, a clinical-stage biotechnology company pioneering a new class of cancer therapeutics, has announced the appointment of Dr. Eyal Attar as its Chief Medical Officer (CMO). The strategic…
EditCo Bio and Promega Team Up to Advance Cell-Based Research In a pivotal move set to reshape the landscape of functional genomics and cell engineering, EditCo Bio, Inc. has announced a strategic licensing agreement with Promega Corporation. This collaboration grants…
TNF Pharmaceuticals and Renova Health Harness AI to Fast-Track Drug Discovery In a significant advancement for data-driven drug development, TNF Pharmaceuticals has announced a strategic collaboration with Renova Health to harness artificial intelligence (AI) and machine learning (ML) technologies in…
Uniphar Expands Cell and Gene Therapy Portfolio with Tenth Project Milestone In a significant advancement that underscores its continued investment in next-generation healthcare solutions, Uniphar, a global leader in pharmaceutical and medtech services, has officially launched its 10th cell and…
QIAGEN Highlights Breakthroughs in Cancer Genomics and Announces Key Partnership Updates at AACR Annual Meeting 2025 QIAGEN N.V. Frankfurt Prime Standard: QIA), a global leader in molecular diagnostics and sample-to-insight technologies, today announced a comprehensive lineup of product innovations and…
6 Key Ways Pharmacists Contribute to Your Health and Wellbeing When it comes to managing your health in a fast-paced world, access to reliable, professional healthcare can make all the difference. While primary care physicians remain essential in diagnosing and…
Cytokinetics Announces Equity Awards Granted Under Nasdaq Listing Rule 5635(c)(4) Cytokinetics, Incorporated has taken another strategic step in fostering long-term company growth through a robust talent acquisition strategy that includes meaningful equity incentives. On April 15, 2025, the company announced…